|
Volumn 35, Issue 2-3, 2005, Pages 297-306
|
Commentary on hormetic dose-response relationships in immunology: Occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE;
ABACAVIR;
ANTIVIRUS AGENT;
COTRIMOXAZOLE;
CYCLOSPORIN A;
ESTROGEN;
FLUOXETINE;
HISTAMINE;
HYDROCORTISONE;
IMMUNOMODULATING AGENT;
NEVIRAPINE;
SEROTONIN ANTAGONIST;
XENOBIOTIC AGENT;
XYLAZINE;
AUTOIMMUNE DISEASE;
B LYMPHOCYTE;
CYTOKINE PRODUCTION;
DOSE RESPONSE;
DRUG HYPERSENSITIVITY;
HORMESIS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE DEFICIENCY;
IMMUNE RESPONSE;
IMMUNOLOGY;
IMMUNOMODULATION;
IMMUNOTOXICITY;
INFECTION SENSITIVITY;
LYMPHOCYTE PROLIFERATION;
MEDICAL RESEARCH;
NONHUMAN;
NOTE;
RISK FACTOR;
TH2 CELL;
TOXICITY TESTING;
XENOBIOTIC METABOLISM;
ADAPTATION;
ANIMAL;
DRUG EFFECT;
METHODOLOGY;
NOMENCLATURE;
RISK ASSESSMENT;
TOXICOLOGY;
ADAPTATION, PHYSIOLOGICAL;
CYCLOSPORINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG HYPERSENSITIVITY;
DRUG THERAPY;
HOMEOSTASIS;
HUMANS;
TERMINOLOGY;
XENOBIOTICS;
ANIMALS;
RISK ASSESSMENT;
TOXICOLOGY;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 15244351524
PISSN: 10408444
EISSN: None
Source Type: Journal
DOI: 10.1080/10408440590917053 Document Type: Note |
Times cited : (10)
|
References (0)
|